Open AccessAssociation between COVID-19 morbidity and mortality rates and BCG vaccination policies in OECD countries
Author(s) -
Yuki Senoo,
Yosuke Suzuki,
Kenji Tsuda,
Tetsuya Tanimoto,
K. Takahashi
Publication year - 2020
Publication title -
journal of infection prevention
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.43
H-Index - 20
eISSN - 1757-1774
pISSN - 1757-1782
DOI - 10.1177/1757177420976812
Subject(s) - covid-19 , vaccination , vaccination policy , coronavirus , medicine , environmental health , development economics , political science , disease , virology , outbreak , economics , infectious disease (medical specialty) , pathology
We compared whether the national BCG vaccination (BCGV) policy influenced coronavirus disease 2019 (COVID-19) in Organisation for Economic Co-operation and Development (OECD) countries. Those currently implementing BCGV have a reduced number of COVID-19 morbidity and mortality cases, compared to those who have never implemented a BCGV policy, suggesting the potential protective effect of BCGV against COVID-19.